Skip to main content
SpringerLink
Log in

Author’s Reply to Liu et al.: “Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab”

  • Letter to the Editor
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

The Original Article was published on 28 October 2020

A Review Article was published on 13 February 2019

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Liu J, Memon AA, Lyu L, Siedlecki A. Comment on “Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an individualized approach to Eculizumab. Clin Pharmacokinet. 2020;. https://doi.org/10.1007/s40262-020-00950-7.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Wijnsma KL, Ter Heine R, Moes D, Langemeijer S, Schols SEM, Volokhina EB, et al. Pharmacology, pharmacokinetics and pharmacodynamics of eculizumab, and possibilities for an individualized approach to eculizumab. Clin Pharmacokinet. 2019;58(7):859–74. https://doi.org/10.1007/s40262-019-00742-8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Sarno L, Tufano A, Maruotti GM, Martinelli P, Balletta MM, Russo D. Eculizumab in pregnancy: a narrative overview. J Nephrol. 2019;32(1):17–25. https://doi.org/10.1007/s40620-018-0517-z.

    Article  CAS  PubMed  Google Scholar 

  4. Stefanovic V. The extended use of eculizumab in pregnancy and complement activation-associated diseases affecting maternal, fetal and neonatal kidneys—the future is now? J Clin Med. 2019;8(3):407. https://doi.org/10.3390/jcm8030407.

    Article  CAS  PubMed Central  Google Scholar 

  5. Stone RH, Hong J, Jeong H. Pharmacokinetics of monoclonal antibodies used for inflammatory bowel diseases in pregnant women. J Clin Toxicol. 2014;4(4):209. https://doi.org/10.4172/2161-0495.1000209.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Richani K, Soto E, Romero R, Espinoza J, Chaiworapongsa T, Nien JK, et al. Normal pregnancy is characterized by systemic activation of the complement system. J Matern Fetal Neonatal Med. 2005;17(4):239–45. https://doi.org/10.1080/14767050500072722.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Seow CH, Leung Y, Vande Casteele N, Ehteshami Afshar E, Tanyingoh D, Bindra G, et al. The effects of pregnancy on the pharmacokinetics of infliximab and adalimumab in inflammatory bowel disease. Aliment Pharmacol Ther. 2017;45(10):1329–38. https://doi.org/10.1111/apt.14040.

    Article  CAS  PubMed  Google Scholar 

  8. Duineveld C, Wijnsma KL, Volokhina EB, van den Heuvel LPB, van de Kar N, Wetzels JFM. Placental passage of eculizumab and complement blockade in a newborn. Kidney Int. 2019;95(4):996. https://doi.org/10.1016/j.kint.2019.01.012.

    Article  PubMed  Google Scholar 

  9. Nagarajah S, Tepel M, Nielsen C, Assing K, Palarasah Y, Andersen LLT, et al. Reduced membrane attack complex formation in umbilical cord blood during eculizumab treatment of the mother: a case report. BMC Nephrol. 2019;20(1):307. https://doi.org/10.1186/s12882-019-1469-9.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Hallstensen RF, Bergseth G, Foss S, Jaeger S, Gedde-Dahl T, Holt J, et al. Eculizumab treatment during pregnancy does not affect the complement system activity of the newborn. Immunobiology. 2015;220(4):452–9. https://doi.org/10.1016/j.imbio.2014.11.003.

    Article  CAS  PubMed  Google Scholar 

  11. Soliris® US prescribing information. 2017. Reference ID 4171013. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/125166s422lbl.pdf. Accessed 21 Oct 2020.

  12. Demers-Mathieu V, Underwood MA, Beverly RL, Nielsen SD, Dallas DC. Comparison of human milk immunoglobulin survival during gastric digestion between preterm and term infants. Nutrients. 2018;10(5):631. https://doi.org/10.3390/nu10050631.

    Article  CAS  PubMed Central  Google Scholar 

  13. Jasion VS, Burnett BP. Survival and digestibility of orally-administered immunoglobulin preparations containing IgG through the gastrointestinal tract in humans. Nutr J. 2015;14:22. https://doi.org/10.1186/s12937-015-0010-7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatric Nephrology, Radboud University Medical Center, Radboud Institute for Molecular Life Science, Amalia Children’s Hospital, PO Box 9101, 6500 HB, Nijmegen, The Netherlands

    Kioa Lente Wijnsma & Nicole C. A. J. van de Kar

  2. Department of Pharmacy, Radboud University Medical Center, Nijmegen, The Netherlands

    Rob ter Heine & Roger J. Brüggemann

  3. Department of Nephrology, Radboud University Medical Center, Nijmegen, The Netherlands

    Jack F. M. Wetzels

Authors
  1. Kioa Lente Wijnsma
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rob ter Heine
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jack F. M. Wetzels
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nicole C. A. J. van de Kar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Roger J. Brüggemann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kioa Lente Wijnsma.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wijnsma, K.L., ter Heine, R., Wetzels, J.F.M. et al. Author’s Reply to Liu et al.: “Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab”. Clin Pharmacokinet 59, 1645–1646 (2020). https://doi.org/10.1007/s40262-020-00952-5

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40262-020-00952-5

Search

Navigation